KEGG changes were mainly enriched in several immune system diseases (e.g., leishmaniasis and rheumatoid arthritis) and immune-related pathways (e.g., TNF signalling pathway, interleukin (IL-17) signalling pathway, and NF-κB signalling pathway). The gene discussed is NFKB1; the disease is immune system disorder.